Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company develops its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare. The Company is active worldwide.

  • Revenue in EUR (TTM)22.36bn
  • Net income in EUR1.94bn
  • Incorporated2017
  • Employees71.80k
More ▼

Institutional shareholders

4.82%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 06 Nov 20249.59m0.85%
Norges Bank Investment Managementas of 30 Jun 20246.94m0.62%
Capital Research & Management Co. (World Investors)as of 30 Sep 20246.92m0.61%
Fidelity Management & Research Co. LLCas of 30 Sep 20245.57m0.49%
BlackRock Fund Advisorsas of 07 Nov 20245.04m0.45%
Capital International Ltd.as of 30 Sep 20244.76m0.42%
T. Rowe Price Associates, Inc. (IM)as of 30 Sep 20244.30m0.38%
Candriam Belgium SAas of 31 Oct 20244.02m0.36%
Amundi Asset Management SA (Investment Management)as of 13 Nov 20243.90m0.35%
BlackRock Asset Management Deutschland AGas of 08 Nov 20243.35m0.30%
More ▼
Data from 30 Jun 2024 - 13 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.